Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
243.4 CHF | +0.72% | -.--% | -.--% |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.65 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.87 times its current sales, is high.
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 65.82B | - | ||
-7.22% | 181B | C+ | ||
-6.72% | 99.52B | C | ||
-10.57% | 45.21B | B- | ||
+8.92% | 43.85B | B- | ||
+11.01% | 42.17B | B+ | ||
+9.65% | 28.75B | B | ||
+18.54% | 25.39B | A- | ||
-9.13% | 23.5B | A- | ||
-12.58% | 22.22B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BDX Stock
- BDX Stock
- Ratings Becton, Dickinson and Company